Royalty Pharma RPRX SEC Filings

NASDAQ RPRX
$64.06 +0.17 (+0.27%)
As of: Sep 4, 2026 · 12:51 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Royalty Pharma plc (RPRX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index